JLJingyi Lin

Jingyi Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jingyi Lin has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Yulei Xie

    Department of Rehabilitation Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, People’s Republic of China

    5 shared publications
  • Yinxu Wang

    Department of Rehabilitation Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong City, China

    3 shared publications
  • Jing-Jing Liu

    Department of Rehabilitation Medicine, Affiliated Hospital of North Sichuan Medical College, 637000 Nanchong, Sichuan, China

    2 shared publications
  • Qiu Nie

    Department of Rehabilitation Medicine, Affiliated Hospital of North Sichuan Medical College, 637000 Nanchong, Sichuan, China

    2 shared publications
  • Xin Chen

    Department of Rehabilitation Medicine, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China

    2 shared publications
  • Anli Hu

    Department of Rehabilitation Medicine, Affiliated Hospital of North Sichuan Medical College , No. 1 Maoyuan South Road, Shunqing District, Nanchong, Sichuan Province 637000

    1 shared publication

Latest Publications

  • Open Access

    Development and Validation of a Machine Learning‑Based Predictive Model for Assessing the Risk of Comorbid Depression in Patients With Asthma

    by Qiu Nie, Xu Deng, Xin Chen, Tianwei Lai, Wen Li, Yutong Liu, Jingyi Lin, Qingsong Ren, Jingjing Liu, Yinxu Wang, et al.

    Objective: The aim of this study was to develop and validate a machine learning model to predict the risk of comorbid depression in asthma patients. Methods: We conducted a retrospective study of 2464 asthma patients with comorbid depression using National Health and Nutrition Examination Survey (NHANES) data. Feature selection was conducted using the Boruta algorithm and the Least Absolute Shrinkage and Selection Operator (LASSO). Eight machine learning algorithms, namely Decision Tree (DT), k-Nearest Neighbors (KNN), Light Gradient Booster Machine (LGBM), Logistic Regression (LR), Random Forest (RF), Support Vector Machine (SVM), eXtreme Gradient Boosting (XGBoost), and Multilayer Perceptron (MLP), were trained using 5-fold cross-validation methodology. Model performance was evaluated through various metrics such as area under the curve (AUC), accuracy, sensitivity, specificity, F1 score, and decision curve analysis (DCA). Interpretation was conducted using SHapley Additive exPlanations (SHAP) analysis, highlighting feature importance. Results: The training set comprised 1724 participants, while the validation set included 740 participants, with a depression prevalence of 14.45%. Significant predictors identified included hypertension, chronic obstructive pulmonary disease (COPD), stroke, sleep questionnaire (SLQ) scores, smoking status, Poverty Index Ratio (PIR), and educational level. The XGBoost model demonstrated superior performance compared with alternative machine learning (ML) algorithms, achieving an AUC of 0.750, an accuracy of 69.1%, a sensitivity of 68.2%, a specificity of 73.8%, and an F1 score of 79%. The SHAP method identified SLQ, PIR, and education level as the primary decision factors influencing the ML model’s predictions. Conclusion: The XGBoost model effectively predicts the risk of depression in asthma patients, serving as a valuable reference for early clinical identification and intervention.


  • Advances in ultrasound-mediated brain drug delivery

    by Yinxu Wang, Qian Wen, Anli Hu, Xin Chen, Jingjing Liu, Jingyi Lin, Yulei Xie

    Objectives: The primary objective of this review is to summarize research cases and recent advances in ultrasound technology for overcoming the blood–brain barrier (BBB) and facilitating drug delivery to the brain, thereby providing insights to promote research on enhancing drug permeation across the BBB. Key findings: This review summarizes recent advances in focused ultrasound combined with microbubbles to enhance BBB permeability for brain-targeted drug delivery. It covers the mechanisms by which ultrasound and microbubbles open the BBB, the factors influencing this process, and their applications in brain diseases. Finally, existing challenges in the field are highlighted, and the prospects for clinical translation are discussed. Summary: Ultrasound combined with microbubble technology can safely, non-invasively, and reversibly open the BBB and deliver drugs, offering novel strategies and methods for the treatment of brain diseases.


  • Open Access

    The Effects of Repetitive Transcranial Magnetic Stimulation on Post-Traumatic Stress Disorder and Parameter Discussion: A Meta-Analysis Based on Randomized Controlled Trials

    by Yin-Xu Wang, Jing-Yi Lin, Chun-Yu Zhang, Jing-Jing Liu, Bang-Qiang Hou, Qiu Nie, Juan Lu, Yu-Lei Xie

    Background: Recovery from posttraumatic stress disorder (PTSD) is an urgent clinical issue. Repetitive transcranial magnetic stimulation (rTMS) has shown advantages in treating PTSD. However, the quality of existing evidence is low. This review aims to evaluate the efficacy and safety of rTMS for PTSD and to explore the key parameters that influence its therapeutic effects. Methods: We searched five electronic databases from their inception through September 22, 2024. Eligible studies were screened and data were extracted; the methodological quality of the included trials was assessed. Meta-analysis was performed using RevMan 5.3, and dose–response analysis was conducted with Stata 18.0. Results: Fifteen studies involving 760 patients were included. There was no statistically significant difference between high-frequency rTMS (HF-rTMS) and low-frequency rTMS (LF-rTMS) (p = 0.24). Neither the > 80% motor threshold (MT) group nor the > 10-day treatment group differed significantly from their respective control groups (80% MT and ≤ 10 days; p > 0.05). The dose-response analysis showed no linear relationship between MT and PTSD Checklist (PCL) (nonlinearity test P=0.008< 0.05), whereas a linear relationship was observed between treatment sessions and PCL scores (linearity test P=0.001< 0.05, nonlinearity test P=0.631> 0.05). As the treatment sessions increased, the PCL scores decreased in a dose-dependent manner. Conclusion: rTMS is an effective and noninvasive treatment for PTSD. However, study findings suggest that there are no statistically significant differences between HF-rTMS and LF-rTMS, or between > 80% MT and < 80% MT groups. Dose–response analysis indicates a positive correlation between increased number of sessions and symptom improvement. Despite limitations such as small sample sizes and high heterogeneity that may affect the robustness and generalizability of the results, this study still recommends prioritizing high-frequency rTMS and increased treatment sessions to enhance therapeutic outcomes.


  • Open Access

    Effects of transcranial direct current stimulation combined with acupuncture therapy on brain network functional connectivity in patients with knee osteoarthritis: a single-center randomized controlled trial

    by Qiu Nie, Fang He, Linghui Dong, Xikai Lin, Jingyi Lin, Yinxu Wang, Yulei Xie

    In this study, we investigated the effects of transcranial direct current stimulation (tDCS) combined with acupuncture therapy on pain, dysfunction and functional connectivity in patients with knee osteoarthritis (KOA), and to evaluate its potential therapeutic value. In this single-center, randomized controlled trial, patients were recruited from May 2023 to August 2024 from the Departments of Rehabilitation, Orthopedics, and Pain Management at the Affiliated Hospital of North Sichuan Medical College. The patients were randomly assigned to three groups, including the acupuncture group, the tDCS group, and the combined acupuncture and tDCS group. All treatments were administered five times a week for two weeks. The condition of the patients was evaluated by the visual analog scale (VAS), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the Lequesne index, and functional near-infrared spectroscopy (fNIRS) before treatment and after two weeks of treatment, respectively. In total, 63 patients were enrolled and randomly assigned to three groups. Three patients were excluded for work-related reasons, fear of acupuncture, or time conflicts repectively, which prevented further follow-up. The VAS score, WOMAC score, and Lequesne indexes of all patients were significantly lower after treatment than before treatment (P < 0.01). Compared to the tDCS group and the acupuncture group, the combined group showed greater improvements in the VAS score, WOMAC score, and Lequesne indexes (P < 0.05). The fNIRS results indicated a significant reduction in the mean cerebral functional connectivity strength based on oxyhemoglobin (HbO2) and deoxyhemoglobin (HbR) across all three groups following treatment (P < 0.05). The functional connectivity strengths of the HbO2-based LPFC ~ LPFC, RPFC ~ RPFC, LMC ~ LMC, RMC ~ RMC, LPFC ~ RPFC, LPFC ~ LMC, LPFC ~ RMC, RPFC ~ LMC, RPFC ~ RMC, LMC ~ RMC; HbR-based LPFC ~ LPFC, RPFC ~ RPFC, LMC ~ LMC, RMC ~ RMC, LPFC ~ LMC, LPFC ~ RMC and LMC ~ RMC in the combined group were significantly lower than those in the acupuncture group (P < 0.05).The HbO2-based LPFC ~ LPFC, RPFC ~ RPFC, LMC ~ LMC, and RMC ~ RMC in the combined group were significantly lower than those in the tDCS group (P < 0.01). Compared to those in the acupuncture group, the HbR-based LPFC ~ LPFC and LMC ~ LMC of the patients in the tDCS group were lower (P < 0.05). The combination therapy of tDCS and acupuncture is better than monotherapy in relieving pain and dysfunction in patients with KOA. The improvement in efficacy may be related to the reduction in brain functional connectivity and may become a new treatment method for treating KOA. ChiCTR2300073819.


  • Open Access

    Advances in Repetitive Transcranial Magnetic Stimulation for the Treatment of Post-traumatic Stress Disorder

    by Jingyi Lin, Qijia Xing, Chunyu Zhang, Yaomin Luo, Xin Chen, Yulei Xie, Yinxu Wang

    Post-traumatic stress disorder (PTSD) is a psychiatric disorder that develops and persists after an individual experiences a major traumatic or life-threatening event. While phar-macological treatment and psychological interventions can alleviate some symptoms, pharmacotherapy is time-consuming with low patient compliance, and psychological interventions are costly. Repetitive Transcranial Magnetic Stimulation (rTMS) is a safe and effective technique for treating PTSD, with advantages such as high compliance, low cost, and simplicity of implementation. It can even simultaneously improve depressive symp-toms in some patients. Current research indicates that high-frequency rTMS shows better therapeutic effects compared to low-frequency rTMS, with no significant difference in the likelihood of adverse reactions between the two. Theta Burst Stimulation (TBS) exhibits similar efficacy to high-frequency rTMS, with shorter duration and significant improve-ment in depressive symptoms. However, it carries a slightly higher risk of adverse reac-tions compared to traditional high-frequency rTMS. Combining rTMS with psychological therapy appears to be more effective in improving PTSD symptoms, with early onset of effects and longer duration, albeit at higher cost and requiring individualized patient con-trol. The most common adverse effect of treatment is headache, which can be improved by stopping treatment or using analgesics. Despite these encouraging data, several aspects remain unknown. Given the highly heterogeneous nature of PTSD, defining unique treat-ment methods for this patient population is quite challenging. There are also considerable differences between trials regarding stimulation parameters, therapeutic effects, and the role of combined psychological therapy, which future research needs to address.